Fig. 9From: Lapatinib and lapatinib plus trastuzumab therapy versus trastuzumab therapy for HER2 positive breast cancer patients: an updated systematic review and meta-analysisMeta-analysis of pCR(ypT0/is ypN0/+)Back to article page